<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Glycogen storage disease type II - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Glycogen_storage_disease_type_II" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Glycogen_storage_disease_type_II" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Glycogen_storage_disease_type_II" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Glycogen_storage_disease_type_II","wgTitle":"Glycogen storage disease type II","wgCurRevisionId":659203445,"wgRevisionId":659203445,"wgArticleId":1010229,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","Articles needing additional references from May 2010","All articles needing additional references","Articles with contributors link","Articles that use a Medicine navs subtemplate","Autosomal recessive disorders","Hepatology","Inborn errors of carbohydrate metabolism","Lysosomal storage diseases","Rare diseases"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Glycogen_storage_disease_type_II","wgRelevantArticleId":1010229,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Acid_maltase_deficiency","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Pompe_vacuoles.jpg/100px-Pompe_vacuoles.jpg","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Glycogen_storage_disease_type_II","wgWikibaseItemId":"Q1365789"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.action.view.redirect","mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Glycogen_storage_disease_type_II skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Glycogen storage disease type II</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"><span class="mw-redirectedfrom">  (Redirected from <a href="/w/index.php?title=Acid_maltase_deficiency&amp;redirect=no" title="Acid maltase deficiency">Acid maltase deficiency</a>)</span></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="metadata plainlinks ambox ambox-content ambox-Refimprove" role="presentation">
<tr>
<td class="mbox-image">
<div style="width:52px"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" data-file-width="262" data-file-height="204" /></a></div>
</td>
<td class="mbox-text"><span class="mbox-text-span">This article <b>needs additional citations for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a></b>. <span class="hide-when-compact">Please help <a class="external text" href="//en.wikipedia.org/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit">improve this article</a> by <a href="/wiki/Help:Introduction_to_referencing/1" title="Help:Introduction to referencing/1">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span> <small><i>(May 2010)</i></small></span></td>
</tr>
</table>
<table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Glycogen storage disease type II</th>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/E74.0">E74.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=271.0">271.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/232300">232300</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb5296.htm">5296</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic908.htm">med/908</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/ped/topic1866.htm#">ped/1866</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></th>
<td><a rel="nofollow" class="external text" href="http://patient.info/doctor/pompes-glycogen-storage-disease">Glycogen storage disease type II</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D006009">D006009</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/GeneReviews" title="GeneReviews">GeneReviews</a></th>
<td class="plainlist">
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK1261/">Glycogen Storage Disease Type II (Pompe Disease)</a></li>
</ul>
</td>
</tr>
</table>
<p><b>Glycogen storage disease type II</b> (also called <b>Pompe disease</b> <span class="nowrap"><span class="IPA nopopups"><a href="/wiki/Help:IPA_for_English" title="Help:IPA for English">/<span style="border-bottom:1px dotted"><span title="/ˈ/ primary stress follows">ˈ</span><span title="'p' in 'pie'">p</span><span title="/ɒ/ short 'o' in 'body'">ɒ</span><span title="'m' in 'my'">m</span><span title="'p' in 'pie'">p</span><span title="/ə/ 'a' in 'about'">ə</span></span>/</a></span></span> or <b>acid maltase deficiency</b>) is an <a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">autosomal recessive</a> <a href="/wiki/Metabolic" title="Metabolic" class="mw-redirect">metabolic</a> disorder<sup id="cite_ref-1" class="reference"><a href="#cite_note-1"><span>[</span>1<span>]</span></a></sup> which damages muscle and nerve cells throughout the body. It is caused by an accumulation of <a href="/wiki/Glycogen" title="Glycogen">glycogen</a> in the <a href="/wiki/Lysosome" title="Lysosome">lysosome</a> due to deficiency of the lysosomal <a href="/wiki/Acid_alpha-glucosidase" title="Acid alpha-glucosidase">acid alpha-glucosidase</a> enzyme. It is the only <a href="/wiki/Glycogen_storage_disease" title="Glycogen storage disease">glycogen storage disease</a> with a defect in lysosomal metabolism, and the first glycogen storage disease to be identified, in 1932 by the Dutch pathologist <a href="/wiki/Joannes_Cassianus_Pompe" title="Joannes Cassianus Pompe">J. C. Pompe</a>.</p>
<p>The build-up of glycogen causes progressive muscle weakness (<a href="/wiki/Myopathy" title="Myopathy">myopathy</a>) throughout the body and affects various body tissues, particularly in the <a href="/wiki/Heart" title="Heart">heart</a>, <a href="/wiki/Skeletal_muscle" title="Skeletal muscle" class="mw-redirect">skeletal muscles</a>, <a href="/wiki/Liver" title="Liver">liver</a> and <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Infantile"><span class="tocnumber">2.1</span> <span class="toctext">Infantile</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Late_onset_form"><span class="tocnumber">2.2</span> <span class="toctext">Late onset form</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Cause"><span class="tocnumber">4</span> <span class="toctext">Cause</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Epidemiology"><span class="tocnumber">7</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#History"><span class="tocnumber">8</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-11"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-12"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There are exceptions, but levels of alpha-glucosidase determines the type of GSD II an individual may have. More alpha glucosidase present in the individuals muscles means symptoms occur later in life and progress more slowly. GSD II is broadly divided into two onset forms based on the age symptoms occur.<sup id="cite_ref-agsdus_2-0" class="reference"><a href="#cite_note-agsdus-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Infantile-onset form is usually diagnosed at 4–8 months; muscles appear normal but are limp and weak preventing them from lifting their head or rolling over. As the disease progresses heart muscles thicken and progressively fail. Without treatment death usually occurs due to heart failure and respiratory weakness.<sup id="cite_ref-agsdus_2-1" class="reference"><a href="#cite_note-agsdus-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Late/later onset form occurs later than one to two years and progresses more slowly than Infantile-onset form. One of the first symptoms is a progressive decrease in muscle strength starting with the legs and moving to smaller muscles in the trunk and arms, such as the diaphragm and other muscles required for breathing. Respiratory failure is the most common cause of death. Enlargement of the heart muscles and rhythm disturbances are not significant features but do occur in some cases.<sup id="cite_ref-agsdus_2-2" class="reference"><a href="#cite_note-agsdus-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=2" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Infantile">Infantile</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=3" title="Edit section: Infantile">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The infantile form usually comes to medical attention within the first few months of life. The usual presenting features are cardiomegaly (92%), <a href="/wiki/Hypotonia" title="Hypotonia">hypotonia</a> (88%), <a href="/wiki/Cardiomyopathy" title="Cardiomyopathy">cardiomyopathy</a> (88%), respiratory distress (78%), muscle weakness (63%), feeding difficulties (57%) and <a href="/wiki/Failure_to_thrive" title="Failure to thrive">failure to thrive</a> (50%).</p>
<p>The main clinical findings include floppy baby appearance, delayed motor milestones and feeding difficulties. Moderate hepatomegaly may be present. Facial features include <a href="/wiki/Macroglossia" title="Macroglossia">macroglossia</a>, wide open mouth wide open eyes, nasal flaring (due to respiratory distress), and poor facial muscle tone. Cardiopulmonary involvement is manifest by increased respiratory rate, use of accessory muscles for respiration, recurrent chest infections, decreased air entry in the left lower zone (due to cardiomegaly), arrhythmias and evidence of heart failure.</p>
<p>Median age at death in untreated cases is 8.7 months and is usually due to cardiorespiratory failure.</p>
<h3><span class="mw-headline" id="Late_onset_form">Late onset form</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=4" title="Edit section: Late onset form">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>This form differs from the infantile principally in the relative lack of cardiac involvement. The onset is more insidious and has a slower progression. Cardiac involvement may occur but is milder than in the infantile form. Skeletal involvement is more prominent with a predilection for the lower limbs.</p>
<p>Late onset features include impaired <a href="/wiki/Cough" title="Cough">cough</a>, recurrent chest infections, <a href="/wiki/Hypotonia" title="Hypotonia">hypotonia</a>, progressive muscle weakness, delayed motor milestones, difficulty swallowing or chewing and reduced vital capacity.</p>
<p>Prognosis depends on the age of onset on symptoms with a better prognosis being associated with later onset disease.</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=5" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Pompe_vacuoles.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Pompe_vacuoles.jpg/220px-Pompe_vacuoles.jpg" width="220" height="163" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Pompe_vacuoles.jpg/330px-Pompe_vacuoles.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Pompe_vacuoles.jpg/440px-Pompe_vacuoles.jpg 2x" data-file-width="2080" data-file-height="1542" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Pompe_vacuoles.jpg" class="internal" title="Enlarge"></a></div>
Muscle biopsy showing large vacuoles in a case of Pompe disease (HE stain, frozen section).</div>
</div>
</div>
<p>The usual initial investigations include chest X ray, <a href="/wiki/Electrocardiogram" title="Electrocardiogram" class="mw-redirect">electrocardiogram</a> and <a href="/wiki/Echocardiography" title="Echocardiography">echocardiography</a>. Typical findings are those of an enlarged heart with non specific conduction defects. Biochemical investigations include <a href="/wiki/Serum_(blood)" title="Serum (blood)">serum</a> <a href="/wiki/Creatine_kinase" title="Creatine kinase">creatine kinase</a> (typically increased 10 fold) with lesser elevations of the serum <a href="/wiki/Aldolase" title="Aldolase">aldolase</a>, <a href="/wiki/Aspartate_transaminase" title="Aspartate transaminase">aspartate transaminase</a>, <a href="/wiki/Alanine_transaminase" title="Alanine transaminase">alanine transaminase</a> and <a href="/wiki/Lactic_dehydrogenase" title="Lactic dehydrogenase" class="mw-redirect">lactic dehydrogenase</a>. Diagnosis is made by estimating the acid alpha glucosidase activity in either skin biopsy (<a href="/wiki/Fibroblast" title="Fibroblast">fibroblasts</a>), muscle biopsy (muscle cells) or in white blood cells. The choice of sample depends on the facilities available at the diagnostic laboratory.</p>
<p>In the late onset form, the findings on investigation are similar to those of the infantile form with the caveat that the creatinine kinases may be normal in some cases. The diagnosis is by estimation of the enzyme activity in a suitable sample.</p>
<p>On May 17, 2013 the Secretary's Discretionary Advisory Committee on Heritable Diseases in Newborns and Children (<a rel="nofollow" class="external text" href="http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/index.html">DACHDNC</a>) approved a recommendation to the <a href="/wiki/United_States_Secretary_of_Health_and_Human_Services" title="United States Secretary of Health and Human Services">Secretary of Health and Human Services</a> to add Pompe to the Recommended Uniform Screening Panel (<a rel="nofollow" class="external text" href="http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendedpanel/index.html">RUSP</a>).<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup> The HHS secretary must first approve the recommendation before the disease is formally added to the panel.</p>
<h2><span class="mw-headline" id="Cause">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=6" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The disease is caused by a mutation in a <a href="/wiki/Gene" title="Gene">gene</a> (<a href="/wiki/Acid_alpha-glucosidase" title="Acid alpha-glucosidase">acid alpha-glucosidase</a>: also known as acid maltase) on long arm of <a href="/wiki/Chromosome_17" title="Chromosome 17" class="mw-redirect">chromosome 17</a> at 17q25.2-q25.3 (base pair 75,689,876 to 75,708,272). The number of mutations described is currently (in 2010) 289 with 67 being non-pathogenic mutations and 197 pathogenic mutations. The remainder are still being evaluated for their association with disease.</p>
<p>The gene spans approximately 20 kb and contains 20 <a href="/wiki/Exon" title="Exon">exons</a> with the first exon being noncoding. The coding sequence of the putative catalytic site domain is interrupted in the middle by an intron of 101 bp. The promoter has features characteristic of a 'housekeeping' gene. The GC content is high (80%) and distinct TATA and CCAAT motifs are lacking.</p>
<p>Most cases appear to be due to three mutations. A <a href="/wiki/Transversion" title="Transversion">transversion</a> (T → G) mutation is the most common among adults with this disorder. This mutation interrupts a site of <a href="/wiki/RNA_splicing" title="RNA splicing">RNA splicing</a>.</p>
<p>The gene encodes a protein — <a href="/wiki/Acid_alpha-glucosidase" title="Acid alpha-glucosidase">acid alpha-glucosidase</a> (EC 3.2.1.20) — which is a lysosomal <a href="/wiki/Hydrolase" title="Hydrolase">hydrolase</a>. The protein is an <a href="/wiki/Enzyme" title="Enzyme">enzyme</a> that normally degrades the alpha -1,4 and alpha -1,6 linkages in <a href="/wiki/Glycogen" title="Glycogen">glycogen</a>, <a href="/wiki/Maltose" title="Maltose">maltose</a> and <a href="/wiki/Isomaltose" title="Isomaltose">isomaltose</a> and is required for the degradation of 1–3% of cellular <a href="/wiki/Glycogen" title="Glycogen">glycogen</a>. The deficiency of this enzyme results in the accumulation of structurally normal glycogen in <a href="/wiki/Lysosome" title="Lysosome">lysosomes</a> and <a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a> in affected individuals. Excessive glycogen storage within lysosomes may interrupt normal functioning of other <a href="/wiki/Organelle" title="Organelle">organelles</a> and lead to cellular injury.</p>
<p>A putative homologue — acid alpha-glucosidase-related gene 1 — has been identified in the <a href="/wiki/Nematode" title="Nematode">nematode</a> <i><a href="/wiki/Caenorhabditis_elegans" title="Caenorhabditis elegans">Caenorhabditis elegans</a></i>.</p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=7" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Cardiac and respiratory complications are treated symptomatically. Physical and occupational therapy may be beneficial for some patients. Alterations in diet may provide temporary improvement but will not alter the course of the disease. Genetic counseling can provide families with information regarding risk in future pregnancies.</p>
<p>On April 28, 2006 the US <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> approved a <a href="/wiki/Biologic_License_Application" title="Biologic License Application">Biologic License Application</a> (BLA) for <a href="/wiki/Myozyme" title="Myozyme" class="mw-redirect">Myozyme</a> (alglucosidase alfa, rhGAA),<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup> the first treatment for patients with Pompe disease, developed by a team of <a href="/wiki/Duke_University" title="Duke University">Duke University</a> researchers. This was based on <a href="/wiki/Enzyme_replacement_therapy" title="Enzyme replacement therapy">enzyme replacement therapy</a> using biologically active recombinant human alglucosidase alfa produced in Chinese Hamster Ovary cells. Myozyme falls under the FDA <a href="/wiki/Orphan_Drug" title="Orphan Drug" class="mw-redirect">Orphan Drug</a> designation and was approved under a priority review.</p>
<p>The FDA has approved Myozyme for administration by intravenous infusion of the solution. The safety and efficacy of Myozyme were assessed in two separate clinical trials in 39 infantile-onset patients with Pompe disease ranging in age from 1 month to 3.5 years at the time of the first infusion. Myozyme treatment clearly prolongs ventilator-free survival and overall survival. Early diagnosis and early treatment leads to much better outcomes. The treatment is not without side effects which include fever, flushing, skin rash, increased heart rate and even shock; these conditions, however, are usually manageable.</p>
<p>Myozyme costs an average of US$300,000 a year and must be taken for the patients' entire life, so some American insurers have refused to pay for it.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup> On August 14, 2006, Health Canada approved Myozyme for the treatment of Pompe disease. On June 14, 2007 the Canadian Common Drug Review issued their recommendations regarding public funding for Myozyme therapy. Their recommendation was to provide funding to treat a very small subset of Pompe patients (Infants less one year of age with cardiomyopathy).<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup> Genzyme received broad approval in the European Union. On May 26, 2010 FDA approved Lumizyme, a similar version of Myozyme, for the treament of late-onset Pompe disease.</p>
<p>A new treatment option for this disease is called <a href="/wiki/Lumizyme" title="Lumizyme" class="mw-redirect">Lumizyme</a>. Lumizyme and Myozyme have the same generic ingredient (Alglucosidase Alfa) and manufacturer (Genzyme Corporation). The difference between these two products is in the manufacturing process. Today, the Myozyme is made using a 160-L <a href="/wiki/Bioreactor" title="Bioreactor">bioreactor</a>, while the Lumizyme uses a 4000-L bioreactor. Because of the difference in the manufacturing process, the FDA claims that the two products are biologically different. Moreover, Lumizyme is FDA approved as replacement therapy for late-onset (noninfantile) Pompe disease without evidence of cardiac hypertrophy in patients 8 years and older. Myozyme is FDA approved for replacement therapy for infantile-onset Pompe disease.</p>
<p>Recent studies on chaperone molecules to be used with myozyme are starting to show promising results on animal models.</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=8" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The prognosis for individuals with Pompe disease varies according to the onset and severity of symptoms. Without treatment the disease is particularly lethal in infants and young children.</p>
<p><a href="/wiki/Myozyme" title="Myozyme" class="mw-redirect">Myozyme</a> (alglucosidase alfa) is a recombinant form of the human enzyme <a href="/wiki/Acid_alpha-glucosidase" title="Acid alpha-glucosidase">acid alpha-glucosidase</a>, and is also currently being used to replace the missing enzyme. In a study<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup> which included the largest cohort of patients with Pompe disease treated with enzyme replacement therapy (ERT) to date findings showed that Myozyme treatment clearly prolongs ventilator-free survival and overall survival in patients with infantile-onset Pompe disease as compared to an untreated historical control population. Furthermore, the study demonstrated that initiation of ERT prior to 6 months of age, which could be facilitated by newborn screening, shows great promise to reduce the mortality and disability associated with this devastating disorder. Taiwan and several states in the United States have started the newborn screening and results of such regimen in early diagnosis and early initiation of the therapy have dramatically improved the outcome of the disease; many of these babies have reached the normal motor developmental milestones.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup></p>
<p>Another factor affecting the treatment response is generation of antibodies against the infused enzyme, which is particularly severe in Pompe infants who have complete deficiency of the acid alpha-glucosidase.<sup id="cite_ref-Amalfitano01_9-0" class="reference"><a href="#cite_note-Amalfitano01-9"><span>[</span>9<span>]</span></a></sup> Immune tolerance therapy to eliminate these antibodies has improved the treatment outcome.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup></p>
<p>A Late Onset Treatment Study (LOTS) was published in 2010.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup> The study was undertaken to evaluate the safety and efficacy of aglucosidase alfa in juvenile and adult patients with Pompe disease. LOTS was a randomized, double-blind, placebo-controlled study that enrolled 90 patients at eight primary sites in the United States and Europe. Participants received either aglucosidase alfa or a placebo every other week for 18 months. The average age of study participants was 44 years. The primary efficacy endpoints of the study sought to determine the effect of Myozyme on functional endurance as measured by the six-minute walk test and to determine the effect of aglucosidase alfa on pulmonary function as measured by percent predicted forced vital capacity.</p>
<p>The results showed that, at 78 weeks, patients treated with aglucosidase alfa increased their distance walked in six minutes by an average of approximately 25 meters as compared with the placebo group which declined by 3 meters (P=0.03). The placebo group did not show any improvement from baseline. The average baseline distance walked in six minutes in both groups was approximately 325 meters. Percent predicted forced vital capacity in the group of patients treated with aglucosidase alfa increased by 1.2 percent at 78 weeks. In contrast, it declined by approximately 2.2 percent in the placebo group (P=0.006).</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=9" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Autorecessive.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/220px-Autorecessive.svg.png" width="220" height="257" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/330px-Autorecessive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/440px-Autorecessive.svg.png 2x" data-file-width="1350" data-file-height="1580" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Autorecessive.svg" class="internal" title="Enlarge"></a></div>
Glycogen storage disease type II has an autosomal recessive pattern of inheritance.</div>
</div>
</div>
<p>The <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> of the disease is approximately 1 in 140,000 for infantile GSD II and 1 in 60,000 for adult GSD II.<sup id="cite_ref-Ausems_12-0" class="reference"><a href="#cite_note-Ausems-12"><span>[</span>12<span>]</span></a></sup> It has been reported in almost all ethnic populations. It has an autosomal recessive inheritance pattern. This means the defective gene is located on an <a href="/wiki/Autosome" title="Autosome">autosome</a>, and two copies of the gene—one from each parent—are required to be born with the disorder. As with all cases of autosomal recessive inheritance, children have a 1 in 4 chance of inheriting the disorder when both parents carry the defective gene, and although both parents carry one copy of the defective gene, they are usually not affected by the disorder.</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=10" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The disease is named after <a href="/wiki/Joannes_Cassianus_Pompe" title="Joannes Cassianus Pompe">Joannes Cassianus Pompe</a>, who characterized it in 1932.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup><sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup> Pompe described accumulation of glycogen in muscle tissue in some cases of a previously unknown disorder. This accumulation was difficult to explain as the enzymes involved in the usual metabolism of glucose and glycogen were all present and functioning.</p>
<p>The basis for the disease remained a puzzle until <a href="/wiki/Christian_de_Duve" title="Christian de Duve">Christian de Duve</a>'s discovery of lysosomes in 1955 for which he won the <a href="/wiki/Nobel_Prize" title="Nobel Prize">Nobel Prize</a> in 1974. His co-worker <a href="/wiki/Henri_G._Hers" title="Henri G. Hers">Henri G. Hers</a> realised in 1965 that the deficiency of a lysosomal enzyme (alpha glucosidase) for the breakdown of glycogen could explain the symptoms of Pompe disease. This discovery led to establishing the concept of lysosomal storage diseases, of which 49 have been described (to date).</p>
<p>Despite recognizing the basis for the disease treatment proved difficult. Administration of the enzyme lead to its uptake by the liver and not the muscle cells where it is needed. In the early 1990s two Dutch scientists, <a href="/w/index.php?title=Arnold_Reuser&amp;action=edit&amp;redlink=1" class="new" title="Arnold Reuser (page does not exist)">Arnold Reuser</a> and <a href="/w/index.php?title=Ans_van_der_Ploeg&amp;action=edit&amp;redlink=1" class="new" title="Ans van der Ploeg (page does not exist)">Ans van der Ploeg</a> a PhD student using alpha-glucosidase containing phosphorylated mannose residues purified from bovine testes, they were able to show that an increase in the enzyme's activity in the normal mouse muscles.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup></p>
<p>Later in 1998, Dr. Yuan-Tsong Chen and colleagues at Duke University (<a href="/w/index.php?title=%E9%99%B3%E5%9E%A3%E5%B4%87&amp;action=edit&amp;redlink=1" class="new" title="陳垣崇 (page does not exist)">陳垣崇</a>,Dr. Chen is currently the director of the Institute of Biomedical Sciences, <a href="/wiki/Academia_Sinica" title="Academia Sinica">Academia Sinica</a>, <a href="/wiki/Taipei" title="Taipei">Taipei</a>, <a href="/wiki/Taiwan" title="Taiwan">Taiwan</a>.), using the enzyme produced in Chinese Hamster Ovary cells demonstrated for the first time that the enzyme can clear the glycogen and improved the muscle function in Pompe disease quail. The results of the work at Duke were impressive with one treated bird recovering to the point of being able to fly again.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup></p>
<p>This was followed by production of clinical grade alpha-glucosidase in Chinese hamster ovary (CHO) cells and in the milk of transgenic rabbits.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup> This work eventually culminated in the start of clinical trials with the first clinical trial including 4 babies receiving enzyme from rabbit milk at <a href="/w/index.php?title=Erasmus_MC_Sophia_Children%E2%80%99s_Hospital&amp;action=edit&amp;redlink=1" class="new" title="Erasmus MC Sophia Children’s Hospital (page does not exist)">Erasmus MC Sophia Children’s Hospital</a> and 3 babies receiving enzyme grown in CHO cells<sup id="cite_ref-Amalfitano01_9-1" class="reference"><a href="#cite_note-Amalfitano01-9"><span>[</span>9<span>]</span></a></sup> at Duke University in 1999.</p>
<p>The currently approved Myozyme is manufactured by Genzyme Corp. in Cambridge, Massachusetts, USA. Its development was a complex process. Genzyme first partnered with Pharming Group NV who had managed to produce acid alpha-glucosidase from the milk of transgentic rabbits. They also partnered with a second group based at Duke University using Chinese hamster ovary cells. In 2001, it acquired Novazyme which was also working on this enzyme. Genzyme also had its own product (Myozyme) grown in CHO cells under development. In November 2001, Genzyme chief executive Henri Termeer organised a systematic comparison of the various potential drugs in a mouse model of Pompe disease. It was found that Duke enzyme was the most efficacious, followed by Myozyme. However, due to easier manufacture of Myozyme, work on the other products was then discontinued.</p>
<p>Funding for research in this field was in part provided by Muscular Dystrophy Association and Acid Maltase Deficiency Association in USA and the Association of Glycogen Storage Disorders in UK and the International Pompe Association.</p>
<p><a href="/wiki/John_Crowley_(biotech_executive)" title="John Crowley (biotech executive)">John Crowley</a> became involved in the fund-raising efforts in 1998 after two of his children were diagnosed with Pompe's. He joined the company Novazyme in 1999, which was working on enzyme replacement treatment for Pompe's. Novazyme was sold to Genzyme in 2001 for over US$100 million. The 2010 film <i><a href="/wiki/Extraordinary_Measures" title="Extraordinary Measures">Extraordinary Measures</a></i> is based on Crowley's search for a cure.</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=11" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><i><a rel="nofollow" class="external text" href="http://ghr.nlm.nih.gov/condition=pompedisease">Pompe disease</a></i> at <a href="/wiki/U.S._National_Library_of_Medicine" title="U.S. National Library of Medicine" class="mw-redirect">NLM</a> Genetics Home Reference</span></li>
<li id="cite_note-agsdus-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-agsdus_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-agsdus_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-agsdus_2-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.agsdus.org/html/typeiipompe.htm">"Type II Glycogen Storage Disease"</a>. The Association for Glycogen Storage Disease<span class="reference-accessdate">. Retrieved <span class="nowrap">22 May</span> 2012</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.btitle=Type+II+Glycogen+Storage+Disease&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.agsdus.org%2Fhtml%2Ftypeiipompe.htm&amp;rft.pub=The+Association+for+Glycogen+Storage+Disease&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation web">Genetic, Alliance. <a rel="nofollow" class="external text" href="http://us5.campaign-archive1.com/?u=a9e55c5fcbe8bce63e2c83eb9&amp;id=0d7b356eb5">"Federal Advisory Committee Recommends Pompe Disease for Newborn Screening"</a>. Genetic Alliance<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-05-17</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.aufirst=Alliance&amp;rft.au=Genetic%2C+Alliance&amp;rft.aulast=Genetic&amp;rft.btitle=Federal+Advisory+Committee+Recommends+Pompe+Disease+for+Newborn+Screening&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fus5.campaign-archive1.com%2F%3Fu%3Da9e55c5fcbe8bce63e2c83eb9%26id%3D0d7b356eb5&amp;rft.pub=Genetic+Alliance&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.fda.gov/bbs/topics/NEWS/2006/NEW01365.html">"FDA Approval News for Myozyme"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2009-12-16</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.btitle=FDA+Approval+News+for+Myozyme&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fbbs%2Ftopics%2FNEWS%2F2006%2FNEW01365.html&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://online.wsj.com/article/SB119007210553130427.html">Burden of Proof: As Costs Rise, New Medicines Face Pushback; Insurers Limit Coverage To FDA-Approved Uses; $300,000 Drug Denied</a> By Geeta Anand, <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>, September 18, 2007.</span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.cadth.ca/media/cdr/complete/cdr_complete_Myozyme_June-14-2007_e.pdf">Canadian Common Drug Review Recommendations on Public Funding for Myozyme</a></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation journal">Wagner KR (2007). "Enzyme replacement for infantile Pompe disease: the first step toward a cure". <i>Neurology</i> <b>68</b> (2): 88–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1212%2F01.wnl.0000253226.13795.40">10.1212/01.wnl.0000253226.13795.40</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17210887">17210887</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=Enzyme+replacement+for+infantile+Pompe+disease%3A+the+first+step+toward+a+cure&amp;rft.aulast=Wagner+KR&amp;rft.au=Wagner+KR&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000253226.13795.40&amp;rft_id=info%3Apmid%2F17210887&amp;rft.issue=2&amp;rft.jtitle=Neurology&amp;rft.pages=88-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation journal">Chien YH; Lee, NC; Thurberg, BL; Chiang, SC; Zhang, XK; Keutzer, J; Huang, AC; Wu, MH et al. (2009). "Pompe disease in infants: improving the prognosis by newborn screening and early treatment". <i>Pediatrics</i> <b>124</b> (6): e1116–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1542%2Fpeds.2008-3667">10.1542/peds.2008-3667</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19948615">19948615</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=Pompe+disease+in+infants%3A+improving+the+prognosis+by+newborn+screening+and+early+treatment&amp;rft.au=Chen%2C+Y.-T.&amp;rft.au=Chiang%2C+SC&amp;rft.au=Chien+YH&amp;rft.au=Huang%2C+AC&amp;rft.au=Huang%2C+PH&amp;rft.au=Hwu%2C+W.-L.&amp;rft.au=Keutzer%2C+J&amp;rft.aulast=Chien+YH&amp;rft.au=Lee%2C+NC&amp;rft.au=Thurberg%2C+BL&amp;rft.au=Tsai%2C+F.-J.&amp;rft.au=Wu%2C+MH&amp;rft.au=Zhang%2C+XK&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1542%2Fpeds.2008-3667&amp;rft_id=info%3Apmid%2F19948615&amp;rft.issue=6&amp;rft.jtitle=Pediatrics&amp;rft.pages=e1116-25&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=124" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Amalfitano01-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Amalfitano01_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Amalfitano01_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Amalfitano A, Bengur AR, Morse RP, Majure JM, Case LE, Veerling DL, Mackey J, Kishnani P, Smith W, McVie-Wylie A, Sullivan JA, Hoganson GE, Phillips JA 3rd, Schaefer GB, Charrow J, Ware RE, Bossen EH, Chen YT (2001). <a rel="nofollow" class="external text" href="http://journals.lww.com/geneticsinmedicine/pages/articleviewer.aspx?year=2001&amp;issue=03000&amp;article=00008&amp;type=abstract">"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial."</a>. <i>Genetics in Medicine</i> <b>3</b> (2): 132–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F00125817-200103000-00008">10.1097/00125817-200103000-00008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11286229">11286229</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=Recombinant+human+acid+alpha-glucosidase+enzyme+therapy+for+infantile+glycogen+storage+disease+type+II%3A+results+of+a+phase+I%2FII+clinical+trial.&amp;rft.au=Amalfitano+A%2C+Bengur+AR%2C+Morse+RP%2C+Majure+JM%2C+Case+LE%2C+Veerling+DL%2C+Mackey+J%2C+Kishnani+P%2C+Smith+W%2C+McVie-Wylie+A%2C+Sullivan+JA%2C+Hoganson+GE%2C+Phillips+JA+3rd%2C+Schaefer+GB%2C+Charrow+J%2C+Ware+RE%2C+Bossen+EH%2C+Chen+YT&amp;rft.aulast=Amalfitano+A%2C+Bengur+AR%2C+Morse+RP%2C+Majure+JM%2C+Case+LE%2C+Veerling+DL%2C+Mackey+J%2C+Kishnani+P%2C+Smith+W%2C+McVie-Wylie+A%2C+Sullivan+JA%2C+Hoganson+GE%2C+Phillips+JA+3rd%2C+Schaefer+GB%2C+Charrow+J%2C+Ware+RE%2C+Bossen+EH%2C+Chen+YT&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjournals.lww.com%2Fgeneticsinmedicine%2Fpages%2Farticleviewer.aspx%3Fyear%3D2001%26issue%3D03000%26article%3D00008%26type%3Dabstract&amp;rft_id=info%3Adoi%2F10.1097%2F00125817-200103000-00008&amp;rft_id=info%3Apmid%2F11286229&amp;rft.issue=2&amp;rft.jtitle=Genetics+in+Medicine&amp;rft.pages=132-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Mendelsohn NJ; Messinger, YH; Rosenberg, AS; Kishnani, PS (2009). "Elimination of antibodies to recombinant enzyme in Pompe disease". <i>N Engl J Med</i> <b>360</b> (2): 194–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMc0806809">10.1056/NEJMc0806809</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19129538">19129538</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=Elimination+of+antibodies+to+recombinant+enzyme+in+Pompe+disease&amp;rft.au=Kishnani%2C+PS&amp;rft.aulast=Mendelsohn+NJ&amp;rft.au=Mendelsohn+NJ&amp;rft.au=Messinger%2C+YH&amp;rft.au=Rosenberg%2C+AS&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMc0806809&amp;rft_id=info%3Apmid%2F19129538&amp;rft.issue=2&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=194-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=360" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Van der Ploeg AT (2010). "A randomized study of alucosidase alfa in late-onset Pompe disease". <i>N Engl J Med</i> <b>362</b> (15): 1396–1406. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa0909859">10.1056/NEJMoa0909859</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20393176">20393176</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=A+randomized+study+of+alucosidase+alfa+in+late-onset+Pompe+disease&amp;rft.aulast=Van+der+Ploeg+AT&amp;rft.au=Van+der+Ploeg+AT&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa0909859&amp;rft_id=info%3Apmid%2F20393176&amp;rft.issue=15&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=1396-1406&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=362" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ausems-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ausems_12-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ausems MG, Verbiest J, Hermans MP et al. (September 1999). "Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling". <i>Eur. J. Hum. Genet.</i> <b>7</b> (6): 713–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.ejhg.5200367">10.1038/sj.ejhg.5200367</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10482961">10482961</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=Frequency+of+glycogen+storage+disease+type+II+in+The+Netherlands%3A+implications+for+diagnosis+and+genetic+counselling&amp;rft.au=Ausems+MG%2C+Verbiest+J%2C+Hermans+MP&amp;rft.aulast=Ausems+MG%2C+Verbiest+J%2C+Hermans+MP&amp;rft.date=September+1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.ejhg.5200367&amp;rft_id=info%3Apmid%2F10482961&amp;rft.issue=6&amp;rft.jtitle=Eur.+J.+Hum.+Genet.&amp;rft.pages=713-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Pompe, J.C. (1932). "Over idiopathische hypertrophie van het hart". <i>Ned. Tijdschr. Geneeskd.</i> <b>76</b>: 304–312.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=Over+idiopathische+hypertrophie+van+het+hart&amp;rft.aulast=Pompe%2C+J.C.&amp;rft.au=Pompe%2C+J.C.&amp;rft.date=1932&amp;rft.genre=article&amp;rft.jtitle=Ned.+Tijdschr.+Geneeskd.&amp;rft.pages=304-312&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=76" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><i><a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/947870-overview">Genetics of Glycogen-Storage Disease Type II (Pompe Disease)</a></i> at <a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Van der Ploeg AT, Kroos MA, Willemsen R, Brons NH, Reuser AJ (February 1991). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC296338">"Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice"</a>. <i>J. Clin. Invest.</i> <b>87</b> (2): 513–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1172%2FJCI115025">10.1172/JCI115025</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC296338">296338</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1991835">1991835</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=Intravenous+administration+of+phosphorylated+acid+alpha-glucosidase+leads+to+uptake+of+enzyme+in+heart+and+skeletal+muscle+of+mice&amp;rft.aulast=Van+der+Ploeg+AT%2C+Kroos+MA%2C+Willemsen+R%2C+Brons+NH%2C+Reuser+AJ&amp;rft.au=Van+der+Ploeg+AT%2C+Kroos+MA%2C+Willemsen+R%2C+Brons+NH%2C+Reuser+AJ&amp;rft.date=February+1991&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC296338&amp;rft_id=info%3Adoi%2F10.1172%2FJCI115025&amp;rft_id=info%3Apmc%2F296338&amp;rft_id=info%3Apmid%2F1991835&amp;rft.issue=2&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.pages=513-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=87" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Kikuchi T, Yang HW, Pennybacker M et al. (February 1998). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC508631">"Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail"</a>. <i>J. Clin. Invest.</i> <b>101</b> (4): 827–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1172%2FJCI1722">10.1172/JCI1722</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC508631">508631</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9466978">9466978</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=Clinical+and+metabolic+correction+of+pompe+disease+by+enzyme+therapy+in+acid+maltase-deficient+quail&amp;rft.au=Kikuchi+T%2C+Yang+HW%2C+Pennybacker+M&amp;rft.aulast=Kikuchi+T%2C+Yang+HW%2C+Pennybacker+M&amp;rft.date=February+1998&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC508631&amp;rft_id=info%3Adoi%2F10.1172%2FJCI1722&amp;rft_id=info%3Apmc%2F508631&amp;rft_id=info%3Apmid%2F9466978&amp;rft.issue=4&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.pages=827-33&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Van den Hout H, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT (July 2000). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0140673600025332">"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients"</a>. <i>Lancet</i> <b>356</b> (9227): 397–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2800%2902533-2">10.1016/S0140-6736(00)02533-2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10972374">10972374</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlycogen+storage+disease+type+II&amp;rft.atitle=Recombinant+human+alpha-glucosidase+from+rabbit+milk+in+Pompe+patients&amp;rft.aulast=Van+den+Hout+H%2C+Reuser+AJ%2C+Vulto+AG%2C+Loonen+MC%2C+Cromme-Dijkhuis+A%2C+Van+der+Ploeg+AT&amp;rft.au=Van+den+Hout+H%2C+Reuser+AJ%2C+Vulto+AG%2C+Loonen+MC%2C+Cromme-Dijkhuis+A%2C+Van+der+Ploeg+AT&amp;rft.date=July+2000&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0140673600025332&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2800%2902533-2&amp;rft_id=info%3Apmid%2F10972374&amp;rft.issue=9227&amp;rft.jtitle=Lancet&amp;rft.pages=397-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=356" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit&amp;section=12" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.pompe.org.uk/">The website of the Pompe's Group of the Association for Glycogen Storage Disease (UK)</a></li>
<li><a rel="nofollow" class="external text" href="http://www.amda-pompe.org/">Acid Maltase Deficiency Association, Inc.</a>—A US patient support group founded in 1995.</li>
<li><a rel="nofollow" class="external text" href="http://www.unitedpompe.com/">United Pompe Foundation</a></li>
<li><a rel="nofollow" class="external text" href="http://www.worldpompe.org/">International Pompe Association</a>—A federation of Pompe disease patient's groups worldwide.</li>
<li><a rel="nofollow" class="external text" href="http://www.pompe.com">Genzyme's Pompe Information site</a></li>
<li><a rel="nofollow" class="external text" href="http://www.fda.gov/bbs/topics/NEWS/2006/NEW01365.html">FDA Approval News for Myozyme</a></li>
<li><a rel="nofollow" class="external text" href="http://www.pompecanada.com/">Canadian Association of Pompe</a></li>
<li><a rel="nofollow" class="external text" href="http://www.hideandseek.org/">Hide &amp; Seek Foundation for Lysosomal Disease Research</a></li>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK1261/">GeneReview/NIH/UW entry on Glycogen Storage Disease Type II (Pompe Disease)</a></li>
<li><a rel="nofollow" class="external text" href="http://www.australianpompe.com/">Australian Pompe's Association</a></li>
<li><a rel="nofollow" class="external text" href="http://glucogenosis.org/portal1/default.asp">Asociación Española de Enfermos de Glucogenosis</a></li>
<li><a rel="nofollow" class="external text" href="http://foodnhealth.org/know-about-pompe-disease-in-detail/">Fact files on Pompe Disease</a></li>
<li><a rel="nofollow" class="external text" href="http://niams.nih.gov/Health_Info/Pompe_Disease/default.asp">Understanding Pompe Disease</a>&#160;- US National Institute of Arthritis and Musculoskeletal and Skin Diseases</li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Inborn_errors_of_carbohydrate_metabolism" title="Template:Inborn errors of carbohydrate metabolism"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Inborn_errors_of_carbohydrate_metabolism" title="Template talk:Inborn errors of carbohydrate metabolism"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Inborn_errors_of_carbohydrate_metabolism&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">Inborn error</a> of <a href="/wiki/Inborn_errors_of_carbohydrate_metabolism" title="Inborn errors of carbohydrate metabolism">carbohydrate metabolism</a>: <a href="/wiki/Monosaccharide" title="Monosaccharide">monosaccharide</a> metabolism disorders (including <a href="/wiki/Glycogen_storage_disease" title="Glycogen storage disease">glycogen storage diseases</a>) (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#.28E73.E2.80.93E74.29_Carbohydrates" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E73–E74</a>, <a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#Disorders_of_carbohydrate_transport_and_metabolism" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">271</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Sucrose" title="Sucrose">Sucrose</a>, transport<br />
(extracellular)</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Disaccharide" title="Disaccharide">Disaccharide</a> catabolism</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lactose_intolerance" title="Lactose intolerance">Lactose intolerance</a></li>
<li><a href="/wiki/Sucrose_intolerance" title="Sucrose intolerance">Sucrose intolerance</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Monosaccharide" title="Monosaccharide">Monosaccharide</a> transport</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Glucose-galactose_malabsorption" title="Glucose-galactose malabsorption">Glucose-galactose malabsorption</a></li>
<li><a href="/wiki/Inborn_errors_of_renal_tubular_transport" title="Inborn errors of renal tubular transport">Inborn errors of renal tubular transport</a> (<a href="/wiki/Renal_glycosuria" title="Renal glycosuria">Renal glycosuria</a>)</li>
<li><a href="/wiki/Fructose_malabsorption" title="Fructose malabsorption">Fructose malabsorption</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hexose" title="Hexose">Hexose</a> → <a href="/wiki/Glucose" title="Glucose">glucose</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Monosaccharide" title="Monosaccharide">Monosaccharide</a> catabolism</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><a href="/wiki/Fructose" title="Fructose">fructose</a>:</span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Essential_fructosuria" title="Essential fructosuria">Essential fructosuria</a></li>
<li><a href="/wiki/Hereditary_fructose_intolerance" title="Hereditary fructose intolerance">Fructose intolerance</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><a href="/wiki/Galactose" title="Galactose">galactose</a>/<a href="/wiki/Galactosemia" title="Galactosemia">galactosemia</a>:</span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Galactokinase_deficiency" title="Galactokinase deficiency">GALK deficiency</a></li>
<li><a href="/wiki/Galactose-1-phosphate_uridylyltransferase_deficiency" title="Galactose-1-phosphate uridylyltransferase deficiency">GALT deficiency</a>/<a href="/wiki/Galactose_epimerase_deficiency" title="Galactose epimerase deficiency">GALE deficiency</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Glucose" title="Glucose">Glucose</a> ⇄ <a href="/wiki/Glycogen" title="Glycogen">glycogen</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Glycogenesis" title="Glycogenesis">Glycogenesis</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Glycogen_storage_disease_type_0" title="Glycogen storage disease type 0">GSD type 0, glycogen synthase</a></li>
<li><a href="/wiki/Glycogen_storage_disease_type_IV" title="Glycogen storage disease type IV">GSD type IV, Andersen's, branching</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Glycogenolysis" title="Glycogenolysis">Glycogenolysis</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;">extralysosomal:</span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Glycogen_storage_disease_type_V" title="Glycogen storage disease type V">GSD type V, McArdle, muscle glycogen phosphorylase</a>/<a href="/wiki/Glycogen_storage_disease_type_VI" title="Glycogen storage disease type VI">GSD type VI, Hers', liver glycogen phosphorylase</a></li>
<li><a href="/wiki/Glycogen_storage_disease_type_III" title="Glycogen storage disease type III">GSD type III, Cori's, debranching</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lysosome" title="Lysosome">lysosomal</a>/<a href="/wiki/Lysosomal_storage_disease" title="Lysosomal storage disease">LSD</a>: <strong class="selflink">GSD type II, Pompe's, glucosidase</strong></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Glucose" title="Glucose">Glucose</a> ⇄ <a href="/wiki/Citric_acid_cycle" title="Citric acid cycle">CAC</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Glycolysis" title="Glycolysis">Glycolysis</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/MODY_2" title="MODY 2">MODY 2</a>/<a href="/wiki/Hyperinsulinemic_hypoglycemia" title="Hyperinsulinemic hypoglycemia">HHF3</a></li>
<li><a href="/wiki/Phosphofructokinase_deficiency" title="Phosphofructokinase deficiency">GSD type VII, Tarui's, phosphofructokinase</a></li>
<li><a href="/wiki/Triosephosphate_isomerase_deficiency" title="Triosephosphate isomerase deficiency">Triosephosphate isomerase deficiency</a></li>
<li><a href="/wiki/Pyruvate_kinase_deficiency" title="Pyruvate kinase deficiency">Pyruvate kinase deficiency</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Gluconeogenesis" title="Gluconeogenesis">Gluconeogenesis</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pyruvate_carboxylase_deficiency" title="Pyruvate carboxylase deficiency">PCD</a></li>
<li><a href="/wiki/Fructose_bisphosphatase_deficiency" title="Fructose bisphosphatase deficiency">Fructose bisphosphatase deficiency</a></li>
<li><a href="/wiki/Glycogen_storage_disease_type_I" title="Glycogen storage disease type I">GSD type I, von Gierke, glucose 6-phosphatase</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pentose_phosphate_pathway" title="Pentose phosphate pathway">Pentose phosphate pathway</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Glucose-6-phosphate_dehydrogenase_deficiency" title="Glucose-6-phosphate dehydrogenase deficiency">Glucose-6-phosphate dehydrogenase deficiency</a></li>
<li><a href="/wiki/Transaldolase_deficiency" title="Transaldolase deficiency">Transaldolase deficiency</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hyperoxaluria" title="Hyperoxaluria">Hyperoxaluria</a>
<ul>
<li><a href="/wiki/Primary_hyperoxaluria" title="Primary hyperoxaluria">Primary hyperoxaluria</a></li>
</ul>
</li>
<li><a href="/wiki/Pentosuria" title="Pentosuria">Pentosuria</a></li>
<li><a href="/wiki/Aldolase_A_deficiency" title="Aldolase A deficiency">Aldolase A deficiency</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Metabolic_navs" title="Template:Metabolic navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Metabolic_navs" title="Template talk:Metabolic navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Metabolic_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">inborn errors of metabolism</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Metabolism" title="Template:Metabolism">Metabolism</a></li>
<li>Enzymes and pathways: <a href="/wiki/Template:Citric_acid_cycle" title="Template:Citric acid cycle">citric acid cycle</a>
<ul>
<li><a href="/wiki/Template:Citric_acid_cycle_enzymes_and_ETC" title="Template:Citric acid cycle enzymes and ETC">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_enzymes" title="Template:Pentose phosphate pathway enzymes">pentose phosphate</a>
<ul>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_intermediates" title="Template:Pentose phosphate pathway intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycoproteins" title="Template:Glycoproteins">glycoproteins</a>
<ul>
<li><a href="/wiki/Template:Glycoprotein_metabolism_enzymes" title="Template:Glycoprotein metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycosaminoglycans" title="Template:Glycosaminoglycans">glycosaminoglycans</a>
<ul>
<li><a href="/wiki/Template:Proteoglycan_metabolism_enzymes" title="Template:Proteoglycan metabolism enzymes">proteoglycan enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Phospholipids" title="Template:Phospholipids">phospholipid</a>
<ul>
<li><a href="/wiki/Template:Phospholipid_metabolism" title="Template:Phospholipid metabolism">metabolism</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cholesterol_and_steroid_metabolism_enzymes" title="Template:Cholesterol and steroid metabolism enzymes">cholesterol and steroid</a>
<ul>
<li><a href="/wiki/Template:Cholesterol_and_steroid_intermediates" title="Template:Cholesterol and steroid intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Sphingolipids" title="Template:Sphingolipids">sphingolipids</a>
<ul>
<li><a href="/wiki/Template:Glycolipid/sphingolipid_metabolism_enzymes" title="Template:Glycolipid/sphingolipid metabolism enzymes" class="mw-redirect">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Eicosanoids" title="Template:Eicosanoids">eicosanoids</a>
<ul>
<li><a href="/wiki/Template:Eicosanoid_metabolism_enzymes" title="Template:Eicosanoid metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Amino_acid_metabolism_enzymes" title="Template:Amino acid metabolism enzymes">amino acid</a>
<ul>
<li><a href="/wiki/Template:Amino_acid_metabolism_intermediates" title="Template:Amino acid metabolism intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Urea_cycle" title="Template:Urea cycle">urea cycle</a>
<ul>
<li><a href="/wiki/Template:Urea_cycle_enzymes" title="Template:Urea cycle enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nucleotide_metabolism_enzymes" title="Template:Nucleotide metabolism enzymes">nucleotide</a>
<ul>
<li><a href="/wiki/Template:Nucleotide_metabolism_intermediates" title="Template:Nucleotide metabolism intermediates">intermediates</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disorders</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Disorders_of_TCA_and_ETC" title="Template:Disorders of TCA and ETC">Citric acid cycle and electron transport chain</a></li>
<li><a href="/wiki/Template:Glycoprotein_disorders" title="Template:Glycoprotein disorders">Glycoprotein</a></li>
<li><a href="/wiki/Template:Proteoglycan_disorders" title="Template:Proteoglycan disorders">Proteoglycan</a></li>
<li><a href="/wiki/Template:Fatty-acid_metabolism_disorders" title="Template:Fatty-acid metabolism disorders">Fatty-acid</a></li>
<li><a href="/wiki/Template:Phospholipid_metabolism_disorders" title="Template:Phospholipid metabolism disorders">Phospholipid</a></li>
<li><a href="/wiki/Template:Defects_of_cholesterol_and_steroid_metabolism" title="Template:Defects of cholesterol and steroid metabolism">Cholesterol and steroid</a></li>
<li><a href="/wiki/Template:Eicosanoid_metabolism_disorders" title="Template:Eicosanoid metabolism disorders">Eicosanoid</a></li>
<li><a href="/wiki/Template:Amino_acid_metabolic_pathology" title="Template:Amino acid metabolic pathology">Amino acid</a></li>
<li><a href="/wiki/Template:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template:Inborn errors of purine-pyrimidine metabolism">Purine-pyrimidine</a></li>
<li><a href="/wiki/Template:Heme_metabolism_disorders" title="Template:Heme metabolism disorders">Heme metabolism</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Other_alimentary_tract_and_metabolism_products" title="Template:Other alimentary tract and metabolism products">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1255
CPU time usage: 0.279 seconds
Real time usage: 0.375 seconds
Preprocessor visited node count: 1653/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 100877/2097152 bytes
Template argument size: 716/2097152 bytes
Highest expansion depth: 10/40
Expensive parser function count: 1/500
Lua time usage: 0.100/10.000 seconds
Lua memory usage: 4.39 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  290.429      1 - -total
 31.88%   92.584      1 - Template:Reflist
 27.44%   79.705      1 - Template:Infobox_disease
 24.71%   71.775      1 - Template:Infobox
 23.77%   69.044      8 - Template:Navbox
 15.78%   45.822      1 - Template:Refimprove
 15.55%   45.172      1 - Template:Carbohydrate_metabolic_pathology
 10.57%   30.698      1 - Template:Ambox
 10.40%   30.209     10 - Template:Cite_journal
  9.06%   26.309      3 - Template:Cite_web
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:1010229-0!*!0!!en!4!* and timestamp 20150712015509 and revision id 659203445
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Glycogen_storage_disease_type_II&amp;oldid=659203445">https://en.wikipedia.org/w/index.php?title=Glycogen_storage_disease_type_II&amp;oldid=659203445</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Autosomal_recessive_disorders" title="Category:Autosomal recessive disorders">Autosomal recessive disorders</a></li><li><a href="/wiki/Category:Hepatology" title="Category:Hepatology">Hepatology</a></li><li><a href="/wiki/Category:Inborn_errors_of_carbohydrate_metabolism" title="Category:Inborn errors of carbohydrate metabolism">Inborn errors of carbohydrate metabolism</a></li><li><a href="/wiki/Category:Lysosomal_storage_diseases" title="Category:Lysosomal storage diseases">Lysosomal storage diseases</a></li><li><a href="/wiki/Category:Rare_diseases" title="Category:Rare diseases">Rare diseases</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Articles_needing_additional_references_from_May_2010" title="Category:Articles needing additional references from May 2010">Articles needing additional references from May 2010</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Glycogen+storage+disease+type+II&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Glycogen+storage+disease+type+II" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Glycogen_storage_disease_type_II"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Glycogen_storage_disease_type_II"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Glycogen_storage_disease_type_II" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Glycogen_storage_disease_type_II" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Glycogen_storage_disease_type_II" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;oldid=659203445" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q1365789" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Glycogen_storage_disease_type_II&amp;id=659203445" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Glycogen+storage+disease+type+II">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Glycogen+storage+disease+type+II&amp;oldid=659203445&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Glycogen_storage_disease_type_II&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Malaltia_de_Pompe" title="Malaltia de Pompe – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Pompeho_choroba" title="Pompeho choroba – Czech" lang="cs" hreflang="cs">Čeština</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Morbus_Pompe" title="Morbus Pompe – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Enfermedad_de_Pompe" title="Enfermedad de Pompe – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%DA%AF%D9%84%DB%8C%DA%A9%D9%88%DA%98%D9%86%D9%88%D8%B2_%D9%86%D9%88%D8%B9_%D8%AF%D9%88" title="گلیکوژنوز نوع دو – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Maladie_de_Pompe" title="Maladie de Pompe – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Malattia_di_Pompe" title="Malattia di Pompe – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%9E%D7%97%D7%9C%D7%AA_%D7%90%D7%92%D7%99%D7%A8%D7%AA_%D7%92%D7%9C%D7%99%D7%A7%D7%95%D7%92%D7%9F_%D7%9E%D7%A1%D7%95%D7%92_2" title="מחלת אגירת גליקוגן מסוג 2 – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-ms"><a href="//ms.wikipedia.org/wiki/Penyakit_Pompe" title="Penyakit Pompe – Malay" lang="ms" hreflang="ms">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Glycogeenstapelingsziekte_type_II" title="Glycogeenstapelingsziekte type II – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E3%83%9D%E3%83%B3%E3%83%9A%E7%97%85" title="ポンペ病 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Choroba_Pompego" title="Choroba Pompego – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Doen%C3%A7a_de_Pompe" title="Doença de Pompe – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%91%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C_%D0%9F%D0%BE%D0%BC%D0%BF%D0%B5" title="Болезнь Помпе – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Glycogen_storage_disease_type_II" title="Glycogen storage disease type II – Simple English" lang="simple" hreflang="simple">Simple English</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Glykogeninlagringssjukdom_typ_II" title="Glykogeninlagringssjukdom typ II – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E9%BE%90%E8%B2%9D%E6%B0%8F%E7%97%87" title="龐貝氏症 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q1365789#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 25 April 2015, at 21:51.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Glycogen_storage_disease_type_II&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":107,"wgHostname":"mw1217"});
}</script>
	</body>
</html>
